Title:
抗B7-H3モノクローナル抗体およびその使用方法
Document Type and Number:
Japanese Patent JP2023502990
Kind Code:
A
Abstract:
B7-H3を標的とする抗体、抗体-薬物コンジュゲート、またはキメラ抗原受容体などの薬剤が本明細書に提供される。その必要がある患者に、有効量のB7-H3標的指向剤を投与する段階を含む、がんを治療する方法が提供される。がんが増加したレベルのB7-H3を発現している場合、患者は治療のために選択され得る。
More Like This:
Inventors:
piunica-worms david
gammon seth
Pisaneschi Federica
gammon seth
Pisaneschi Federica
Application Number:
JP2022528591A
Publication Date:
January 26, 2023
Filing Date:
November 18, 2020
Export Citation:
Assignee:
BOARD OF REGENTS,THE UNIVERSITY OF TEXAS SYSTEM
International Classes:
C12N15/13; A61K35/17; A61K39/395; A61K45/00; A61K47/68; A61K48/00; A61P35/00; A61P43/00; C07K16/28; C07K16/46; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/0783; C12N5/10; C12N5/12; C12N15/12; C12N15/62; C12N15/63; C12P21/08; C12Q1/04; G01N33/574
Attorney, Agent or Firm:
Shimizu Hatsushi
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Hideki Kodera
Masato Ozeki
Kazuya Kawamoto
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Hideki Kodera
Masato Ozeki
Kazuya Kawamoto
Previous Patent: Indium gallium nitride structures and devices
Next Patent: Androgen receptor/AKR1C3 dual inhibitor
Next Patent: Androgen receptor/AKR1C3 dual inhibitor